prodisc C; prodisc C SK; prodisc C Nova; prodisc C Vivo Instruments
Centinel Spine, LLC · Decision date Oct 7, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-07 for K263159, a special 510(k) from Centinel Spine, LLC of West Chester, Pennsylvania. The listed device name covers prodisc® C, prodisc® C SK, prodisc® C Nova and prodisc® C Vivo Instruments, classified under product code QLQ as manual instruments designed for use with total disc replacement devices, within the orthopedic specialty and review panel. The application was received 09/09/2026 and was not reviewed by a third party.
SESE means the submission was cleared as substantially equivalent; it is not a PMA approval. The public record does not state which components or changes were assessed, what predicate device was cited, or what the clearance permits beyond the instrument classification. No clinical, efficacy or patient-selection conclusions are supported by this record, and the underlying decision documents were not reviewed here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 7, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K263159
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Centinel Spine, LLC
- Product code
- QLQ
- Decision code
- SESE
- Decision date
- Oct 7, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Manual Instruments Designed For Use With Total Disc Replacement Devices.
- Applicant
- Centinel Spine, LLC
- Product code
- QLQ
- FDA device class
- 2
FDA decision timeline
K263159 received
Application receipt date recorded by FDA.
K263159 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Centinel Spine, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- West Chester, PA
Sources and methodology
- Original FDA record: K263159
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records